Short Interest in Yield10 Bioscience, Inc. (NASDAQ:YTEN) Expands By 292.2%

Yield10 Bioscience, Inc. (NASDAQ:YTEN) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 940,900 shares, an increase of 292.2% from the March 15th total of 239,900 shares. Based on an average daily volume of 4,820,000 shares, the short-interest ratio is presently 0.2 days.

Yield10 Bioscience Trading Down 11.2 %

NASDAQ:YTEN opened at $0.33 on Thursday. Yield10 Bioscience has a 1 year low of $0.18 and a 1 year high of $3.29. The firm has a 50 day moving average of $0.29 and a 200-day moving average of $0.27. The stock has a market capitalization of $5.13 million, a P/E ratio of -0.16 and a beta of 1.58.

Analysts Set New Price Targets

Separately, Lake Street Capital cut shares of Yield10 Bioscience from a “buy” rating to a “hold” rating in a research note on Thursday, February 8th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Yield10 Bioscience stock. Millennium Management LLC acquired a new position in Yield10 Bioscience, Inc. (NASDAQ:YTEN) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 58,768 shares of the specialty chemicals company’s stock, valued at approximately $132,000. Millennium Management LLC owned about 1.20% of Yield10 Bioscience at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.91% of the company’s stock.

Yield10 Bioscience Company Profile

Yield10 Bioscience, Inc operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions.